Drugs like semaglutide (brand names Wegovy and Ozempic) and tirzepatide (brand name Zepbound and Mounjaro) have shown remarkable effectiveness in helping people lose weight often 15 percent or more of their body weight
Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, et al
To suppress appetite effectively, semaglutide GLP-1 is typically administered once a week via injection
GLP-1s have moved from social media, family group chats, and dinner-table discussions to clinical conversations to employer benefits meetings, almost overnight
Additionally, AOD 9604 inhibits lipogenesis (new fat formation), particularly in abdominal fat cells, creating a dual action involving the breakdown of existing fat and the prevention of new fat storage
Krauss also notes that there may be something else happening behind the scenes that would cause these patients to be on semaglutide, but has nothing to do with the medication itself